Abstract:The application of microbiome-based therapies in various areas of human disease has recently increased. In chronic respiratory disease, microbiome-based clinical applications are considered compelling options due to the limitations of current treatments. The lung microbiome is ecologically dynamic and affected by various conditions, and dysbiosis is associated with disease severity, exacerbation, and phenotype as well as with chronic respiratory disease endotype. However, it is not easy to directly modulate the lung microbiome. Additionally, studies have shown that chronic respiratory diseases can be improved by modulating gut microbiome and administrating metabolites. Although the composition, diversity, and abundance of the microbiome between the gut and lung are considerably different, modulation of the gut microbiome could improve lung dysbiosis. The gut microbiome influences that of the lung via bacterial-derived components and metabolic degradation products, including short-chain fatty acids. This phenomenon might be associated with the cross-talk between the gut microbiome and lung, called gut-lung axis. There are multiple alternatives to modulate the gut microbiome, such as prebiotics, probiotics, and postbiotics ingestion and fecal material transplantation. Several studies have shown that high-fiber diets, for example, present beneficial effects through the production of short-chain fatty acids. Additionally, genetically modified probiotics to secrete some beneficial molecules might also be utilized to treat chronic respiratory diseases. Further studies on microbial modulation to regulate immunity and potentiate conventional pharmacotherapy will improve microbiome modulation techniques, which will develop as a new therapeutic area in chronic respiratory diseases.

Application of Metabolomics Approaches to Study of Chronic Respiratory Inflammatory Diseases

Metabolomics of Respiratory Diseases

Application of Metabolomics Across the Spectrum of Pulmonary and Critical Care Medicine

Advances in metabolomics of chronic obstructive pulmonary disease

An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary Disease

Research Progress of Metabolomics in Asthma

Metabolomics as a valid analytical technique in environmental exposure research: application and progress

The Application of Metabonomics to Clinical Research and the Progress

Exploring the Potential Role of Metabolomics in COPD: A Concise Review

Metabolomic profiling of anaerobic and aerobic energy metabolic pathways in chronic obstructive pulmonary disease

Application of metabolomics to characterize environmental pollutant toxicity and disease risks

LSC Abstract – Systemic and Local Metabolomics Profiling Reveals Novel Insights into the Progression of Emphysema

[Application of Metabolomics in Research of Plant Metabolites].

Biomarkers for Respiratory Diseases: Present Applications and Future Discoveries

Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease.

Application of Microbiome-Based Therapies in Chronic Respiratory Diseases

The Translational Potential of the Lung Microbiome As a Biomarker and a Therapeutic Target for Chronic Obstructive Pulmonary Disease

Application of Metabolomics Experimental Technology in the Scientific Research of Traditional Chinese Medicine

Discovery of Metabolite Biomarkers: Flux Analysis and Reaction-Reaction Network Approach

Metabolomics Meets Systems Immunology

Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage